pyruvaldehyde has been researched along with transforming growth factor beta in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, T; Hirahara, I; Ishibashi, Y; Kaname, S; Kusano, E | 1 |
Birek, J; Chan, M; Laschinger, C; Lee, W; McCulloch, CA; Simmons, CA; Sivagurunathan, K; Talior, I; Won, E; Young, EW; Yuen, A | 1 |
Chan, LY; Cheng, AS; Lai, KN; Lan, HY; Leung, JC; Lin, M; Tang, SC | 1 |
Ibi, Y; Ido, A; Kanmura, S; Minami, M; Nakahara, M; Tanoue, S; Tokunaga, K; Yoshimine, H | 1 |
Agrewala, JN; Aqdas, M; Arora, A; Bashir, H; Bhalla, V; Maurya, SK; Singh, S | 1 |
5 other study(ies) available for pyruvaldehyde and transforming growth factor beta
Article | Year |
---|---|
Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
Topics: Animals; Base Sequence; Cells, Cultured; Collagen Type I; Dialysis Solutions; DNA Primers; Epithelial Cells; Formaldehyde; Gene Expression; Glucose; Humans; Male; Matrix Metalloproteinase 2; Mesoderm; Peritoneal Dialysis; Peritoneum; Polymerase Chain Reaction; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Snail Family Transcription Factors; Transcription Factors; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2009 |
Methylglyoxal-modified collagen promotes myofibroblast differentiation.
Topics: Actins; Biomarkers; Cadherins; Cell Differentiation; Cell Movement; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Gels; Humans; Muscle, Smooth; Myocardium; Myofibroblasts; Pyruvaldehyde; Transforming Growth Factor beta | 2010 |
Differential effects of advanced glycation end-products on renal tubular cell inflammation.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Chemokine CCL2; Connective Tissue Growth Factor; Epithelial Cells; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Inflammation Mediators; Interleukin-6; Kidney Tubules, Proximal; Lysine; Nephritis, Interstitial; NF-kappa B; Pyruvaldehyde; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rosiglitazone; Serum Albumin; Serum Albumin, Bovine; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2011 |
Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model.
Topics: Actins; Animals; Collagen Type I; Collagen Type III; Disease Models, Animal; Gene Expression; Hepatocyte Growth Factor; Interleukin-1beta; Macrophages; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Myofibroblasts; Peritoneal Fibrosis; Peritonitis; Pyruvaldehyde; Recombinant Proteins; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation | 2021 |
Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system.
Topics: Arginase; B7-H1 Antigen; Cytokines; Dendritic Cells; Glucose; Hepatitis A Virus Cellular Receptor 2; Interleukin-10; Interleukin-12; Interleukin-6; Lipids; Mycobacterium tuberculosis; Myeloid-Derived Suppressor Cells; Nitric Oxide; Pyruvaldehyde; Receptors, CCR7; Th1 Cells; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2022 |